High Priority Status: No / N/A
CBE Number: N/A
Percentage of patients aged 6 months to 12 years of age with a diagnosis of otitis media with effusion (OME) including chronic serous, mucoid, or nonsuppurative OME of ≥ 3 months duration who had or received an order or referral for comprehensive audiometric evaluation.
This measure is to be submitted a minimum of once per performance period for patients diagnosed with OME including chronic serous, mucoid, or nonsuppurative OME of ≥ 3 months duration. This measure may be submitted by clinicians based on the services provided and the measure-specific denominator coding.
All patients aged 6 months through 12 years of age with a diagnosis of OME including chronic serous, mucoid, or nonsuppurative OME of ≥ 3 months duration
To meet the denominator criteria, the measure requires 2 visits for acute OME or 1 visit with a chronic OME diagnosis. The acute OME diagnosis must be charted for both encounters to establish OME as chronic and of greater than 3 months duration. The acute diagnosis code does not need to be the same for both visits. A patient may have acute OME during the first visit and acute or chronic OME during the second visit. OME must be diagnosed on the same side during each visit (e.g., OME in left ear during first visit must be in left ear or bilateral during second visit; or bilateral OME during 1st visit can be either bilateral, left, or right during second visit).
Patients who had a hearing test within 6 months of the original chronic diagnosis of OME including chronic serous, mucoid, or nonsuppurative OME.
Patients who had or received an order or referral for comprehensive audiometric evaluation
To meet the intent of the measure, documentation is required that a comprehensive audiometric evaluation was performed or a referral was made during the encounter in which chronic OME is established. Comprehensive audiometric evaluation is typically performed by an audiologist, but the specific methods will vary with the age of the child.
Patients who had a hearing test within 6 months of the original diagnosis of OME including chronic serous,
mucoid, or nonsuppurative OME.
- Submission Pathway: Traditional MIPS, MIPS Value Pathways
- Measure Type: Process
- High Priority Type: N/A
- Meaningful Measures Area: Preventive Care
- Care Setting(s): Ambulatory Care: Clinician Office/Clinic
- Includes Telehealth: Yes
- Number of Performance Rates: 1
- Inverse measure: No
- Continuous measure: No
- Proportional measure: Yes
- Ratio measure: No
- Risk Adjusted measure: No
© 2024 American Academy of Otolaryngology–Head and Neck Surgery Foundation. All rights reserved.
Limited proprietary coding is contained in the measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the measures for commercial gain, or incorporation of the measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the measures require a license agreement between the user and the American Academy of Otolaryngology – Head and Neck Surgery Foundation.
The measure is not a clinical guideline, does not establish a standard of medical care, and has not been tested for all potential applications. The measure and specifications are provided “as is” without warranty of any kind. Neither the American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF), nor its members shall be responsible for any use of the measure. The AAO-HNSF and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT®) or other coding contained in the specifications.